Prime Medicine (PRME) announced the appointment of Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer, CBO. Most recently, Hawryluk served as Chief Business Officer at AIRNA Corporation
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Intellia Therapeutics price target lowered to $9 from $14 at Wedbush
- Prime Medicine price target raised to $5 from $4 at Citi
- PRME Earnings this Week: How Will it Perform?
- Cathie Wood Loads Up on Klarna, Synopsys, and Rubrik, Trims Shopify and Roblox Stocks
- Cathie Wood’s ARK Investment buys 231K shares of Prime Medicine today